Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts

8Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Estrogen is an important regulator of dermal fibroblast functions, including extracellular matrix (ECM) synthesis. Estrogen mediates its effects through estrogen receptors (ERs), ERα and ERΒ; however, regulation of ERs in dermal fibroblasts remains poorly understood. Friend leukemia integration factor 1 (Fli1), a member of the Ets transcription factor family, has been shown to play a pivotal role in regulation of the ECM genes in dermal fibroblasts. The aim of this study was to examine a possible interaction between Fli1 and estrogen pathways, focusing on ERα. We show that treatment of human dermal fibroblasts with transforming growth factor-Β (TGF-Β) increases ERα protein and mRNA levels. Similarly, ERα expression was increased in response to small interfering RNA (siRNA)-mediated depletion of Fli1, suggesting that Fli1 is a mediator of the TGF-Β effects on ERα expression. Accordingly, we showed that Fli1 binds to the most proximal region of the ERα promoter, and dissociates from the promoter upon TGF-Β treatment. An inverse correlation between Fli1 and ERα expression levels was confirmed in cultured skin fibroblasts obtained from Fli1+/- mice and in the skin of Fli1+/- mice in vivo. This study supports a role of Fli1 as a negative regulator of the ERα gene in dermal fibroblasts. © 2011 The Society for Investigative Dermatology.

Cite

CITATION STYLE

APA

Hattori, T., Stawski, L., Nakerakanti, S. S., & Trojanowska, M. (2011). Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts. Journal of Investigative Dermatology, 131(7), 1469–1476. https://doi.org/10.1038/jid.2011.63

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free